Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma
Open Access
- 12 June 2003
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 348 (24), 2396-2406
- https://doi.org/10.1056/nejmoa022628
Abstract
The use of involved-field radiotherapy after chemotherapy for advanced Hodgkin's lymphoma is controversial.Keywords
This publication has 34 references indexed in Scilit:
- Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup TrialJournal of Clinical Oncology, 2003
- Intensive Salvage Therapy With High-Dose Chemotherapy for Patients With Advanced Hodgkin's Disease in Relapse or Failure After Initial Chemotherapy: Results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 TrialJournal of Clinical Oncology, 2002
- Long-term complications of treatment and causes of mortality after Hodgkin's diseaseSeminars in Radiation Oncology, 1996
- Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVDNew England Journal of Medicine, 1992
- Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's DiseaseAnnals Of Oncology, 1992
- Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.BMJ, 1992
- Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocolsInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Leukemia Following Hodgkin's DiseaseNew England Journal of Medicine, 1990
- Risk of Second Cancers after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1988
- RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE: Relation to Age, Cumulative Dose of Alkylating Agents, and Time from ChemotherapyThe Lancet, 1987